Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Commercial Biotechnology Separation Systems - Global Strategic Business Report: Capture the $6.5B Surge by 2032 as 3M, Agilent, Merck KGaA, and Sartorius Disrupt Bioprocessing

globenewswire.com
MMM 3M Company is mentioned as a featured participant in the commercial biotechnology separation systems market report, indicating its involvement in the industry. BDX Becton Dickinson and Company is identified as a featured participant in the commercial biotechnology separation systems market report, highlighting its presence in the sector. BIO Bio-Rad Laboratories Inc. is mentioned as a featured participant in the commercial biotechnology separation systems market report, indicating its involvement in the industry. GEHC GE Healthcare is identified as a featured participant in the commercial biotechnology separation systems market report, highlighting its presence in the sector. ILMN Illumina Inc. is mentioned as a featured participant in the commercial biotechnology separation systems market report, indicating its involvement in the industry. RGEN Repligen Corporation is identified as a featured participant in the commercial biotechnology separation systems market report, highlighting its presence in the sector. TMO Thermo Fisher Scientific Inc. is mentioned as a featured participant in the commercial biotechnology separation systems market report, indicating its involvement in the industry.

Commercial Biotechnology Separation Systems - Global Strategic Business Report: Capture the $6.5B Surge by 2032 as 3M, Agilent, Merck KGaA, and Sartorius Disrupt Bioprocessing Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Commercial Biotechnology Separation Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global commercial biotechnology separation systems market was valued at US$13.2 billion in 2025 and is projected to reach US$19.7 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.9%. The market outlook reflects sustained demand for advanced purification and analytical technologies across pharmaceuticals, biopharmaceuticals, food and beverages, agriculture, environmental applications, research laboratories and academic institutions.

Commercial biotechnology separation systems support the purification, isolation and analysis of proteins, biomolecules and other biological materials. Market growth is being driven by rising biopharmaceutical production, the increasing prevalence of chronic diseases, the expansion of personalized medicine and stringent regulatory requirements governing product purity, quality and manufacturing consistency. Compliance with Good Manufacturing Practices and other quality standards continues to encourage investment in high-performance chromatography, centrifugation, membrane filtration and electrophoresis systems.

Technological innovation is improving separation efficiency, scalability and process control. Recent developments include cloud-enabled life sciences platforms and multi-column chromatography systems designed to enhance productivity and accommodate evolving bioprocessing requirements. Advances in materials science are also helping manufacturers achieve higher yields and purity levels while reducing processing time and operational costs.

Digital transformation is another important market catalyst. The integration of artificial intelligence, machine learning, connected sensors and real-time monitoring capabilities enables biotechnology companies to optimize separation processes, improve quality control and identify potential production issues earlier. Global demand for vaccines, therapeutic proteins and other biologics has further reinforced the strategic importance of reliable separation infrastructure in public health preparedness and commercial manufacturing.

Market Segment and Regional Outlook

The centrifugation technology segment is forecast to reach US$5.4 billion by 2032, representing a CAGR of 4.4%. Chromatography technology is expected to record stronger growth at a CAGR of 7.1% during the analysis period, supported by its extensive role in biologics purification and analytical workflows.

The United States commercial biotechnology separation systems market was valued at approximately US$3.6 billion in 2025. China is forecast to expand at a CAGR of 8.8% and reach US$4 billion by 2032, reflecting biotechnology investment, growing biopharmaceutical capacity and increasing research activity. The report also evaluates market trends in Japan, Canada, Germany and other major economies across Europe and Asia-Pacific.

Domain Expert Insights

The report combines perspectives from industry specialists, enterprise leaders and academic experts with validated information from conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports and institutional publications. The report tracks emerging market signals, company activity and relevant industry discussions that may not yet be fully reflected in conventional secondary research.

This intelligence is used to connect early developments with broader strategic market direction, helping organizations understand where demand is moving, which technologies are gaining importance and how competitive conditions differ by geography. Market share is examined where analytically relevant, recognizing that competitive structures can vary significantly among regions and technology categories.

Key Questions Addressed

Report Benefits and Features

Companies Featured

Featured participants include 3M Company, AB Sciex, Agilent Technologies Inc., Alfa Laval AB, Alfa Wassermann Separation Technologies LLC, Beckman Coulter Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Flottweg SE, Fluidigm Corporation, GE Healthcare, Hitachi High-Technologies Corp., Illumina Inc., Merck KGaA, Pall Corporation, PerkinElmer Inc., ProMetic Life Sciences Inc., Repligen Corporation, Sartorius Stedim Biotech SA, Shimadzu Scientific Instruments, Sysmex Partec GmbH and Thermo Fisher Scientific Inc.

The report provides decision-makers with a focused assessment of market opportunities, technology adoption, regional expansion and competitive positioning in the global commercial biotechnology separation systems industry.

Key Attributes:

For more information about this report visit https://www.researchandmarkets.com/r/pg7536

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.